PRAME (Preferentially Expressed Antigen in Melanoma) is a tumor-associated antigen that is preferentially expressed in the nuclei of malignant melanocytes. The new anti-PRAME antibody provides valuable complementary information in situations where antibodies against Hmb-45, Melan A, and SOX10 do not provide sufficient diagnostic insights to differentiate between benign and malignant melanocytic lesions. The antibodies from the German manufacturer QUARTERR GmbH offer the assurance of the highest quality at the best prices on the market.

​

WE INVITE YOU TO TEST IT OUT!